MOLN

$0.00

(

+0.00%

) Quote details
Add to Watchlist Run Backtest
stock

Molecular Partners AG ADR

NASDAQ | MOLN

4.12

USD

+$0.00

(

+0.00%

)

At Close (As of Nov 28, 2025)

$153.34M

Market Cap

-

P/E Ratio

-2

EPS

$5.99

52 Week High

$3.36

52 Week Low

HEALTHCARE

Sector

MOLN Chart

Recent Chart
Price Action

MOLN Technicals

Tags:

MOLN Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (CHF)
Gross Profit -$43M
Total Revenue $5M
Cost Of Revenue $48M
Costof Goods And Services Sold $48M
Operating Income -$61M
Selling General And Administrative $17M
Research And Development $49M
Operating Expenses $19M
Investment Income Net -
Net Interest Income $3.3M
Interest Income $3.4M
Interest Expense $25K
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $2.4M
Income Before Tax -$54M
Income Tax Expense $2K
Interest And Debt Expense -
Net Income From Continuing Operations -$54M
Comprehensive Income Net Of Tax -
Ebit -$54M
Ebitda -$52M
Net Income -$54M

Revenue & Profitability

Earnings Performance

MOLN Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (CHF)
Total Assets $159M
Total Current Assets $154M
Cash And Cash Equivalents At Carrying Value $64M
Cash And Short Term Investments $64M
Inventory -
Current Net Receivables $286K
Total Non Current Assets $4.2M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets $49K
Intangible Assets Excluding Goodwill $49K
Goodwill -
Investments -
Long Term Investments -
Short Term Investments $86M
Other Current Assets $4.6M
Other Non Current Assets -
Total Liabilities $17M
Total Current Liabilities $11M
Current Accounts Payable $679K
Deferred Revenue -
Current Debt -
Short Term Debt $1.2M
Total Non Current Liabilities $6.1M
Capital Lease Obligations $2.4M
Long Term Debt -
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $2.4M
Other Current Liabilities $8.9M
Other Non Current Liabilities -
Total Shareholder Equity $142M
Treasury Stock -
Retained Earnings -$246M
Common Stock $4M
Common Stock Shares Outstanding $34M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (CHF)
Operating Cashflow -$59M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $2.4M
Capital Expenditures $723K
Change In Receivables -
Change In Inventory -
Profit Loss -
Cashflow From Investment $40M
Cashflow From Financing $14M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity $0
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$54M

yearly Income Statement (As of Dec 31, 2024)

Field Value (CHF)
Gross Profit -$43M
Total Revenue $5M
Cost Of Revenue $48M
Costof Goods And Services Sold $48M
Operating Income -$61M
Selling General And Administrative $17M
Research And Development $49M
Operating Expenses $19M
Investment Income Net -
Net Interest Income $3.3M
Interest Income $3.4M
Interest Expense $25K
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $2.4M
Income Before Tax -$54M
Income Tax Expense $2K
Interest And Debt Expense -
Net Income From Continuing Operations -$54M
Comprehensive Income Net Of Tax -
Ebit -$54M
Ebitda -$52M
Net Income -$54M

MOLN News

MOLN Profile

Molecular Partners AG ADR Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

Molecular Partners AG (MOLN) is a dynamic clinical-stage biopharmaceutical company headquartered in Schlieren, Switzerland, dedicated to developing cutting-edge protein-based therapeutics for oncology and viral infections. Utilizing its proprietary Darpin and Drug Conjugate technology platforms, the company focuses on creating targeted therapies that improve efficacy and reduce side effects, aiming to address critical unmet medical needs. With a robust clinical pipeline and a commitment to innovation, Molecular Partners is strategically positioned to make significant contributions to the biopharmaceutical industry and enhance patient outcomes.

LPTX
+368.57%
$2.05
KTTA
+38.67%
$1.47
NVDA
-1.80%
$177.00
HBI
-1.82%
$6.47
AMZE
+21.21%
$0.48
VINE
+21.21%
$0.48
TLRY
-21.06%
$0.81
INTC
+10.18%
$40.56
BITF
+12.25%
$3.48
IPG
-1.95%
$24.57
TWOH
-15.38%
$0.00
BYND
-3.74%
$0.98
YGMZ
-9.59%
$0.11
AXDX
-61.36%
$0.03
BMNR
+4.34%
$33.12
CLSK
+12.26%
$15.10
ADAP
-15.14%
$0.05
RUBI
-26.17%
$0.15
ASST
-0.88%
$1.12
PLUG
+1.51%
$2.01
SOND
-23.45%
$0.12
SNAP
+0.91%
$7.68
RMBL
+60.50%
$3.21
LNW
-3.71%
$86.22
INHD
-0.99%
$0.22
ADD
-25.47%
$0.05
CHR
-3.48%
$0.04
BIYA
+17.05%
$0.29
AAL
+0.86%
$14.05
TSLA
+0.84%
$430.17
SRM
+53.27%
$10.30
CIFR
+6.26%
$20.35
BMNU
+8.84%
$8.18
ONMD
+30.28%
$1.85
ONDS
-4.12%
$7.90
MARA
+6.30%
$11.81
WULF
+4.51%
$15.51
NIO
+0.73%
$5.50
F
+0.68%
$13.28
BURU
+9.84%
$0.24
GPUS
-9.24%
$0.30
WLGS
-5.57%
$0.04
MTSR
-0.35%
$70.50
VALE
+0.79%
$12.61
SOFI
+4.31%
$29.72
GOOGL
+0.07%
$320.18
BTBT
+2.58%
$2.38
DEFT
+9.35%
$1.52
ADTX
+21.01%
$3.80
BTG
+3.35%
$4.62
DVLT
-4.69%
$2.03
GRAB
+2.44%
$5.45
ACHR
+4.00%
$7.79
AFMD
-34.94%
$0.18
PFE
+0.11%
$25.74
CRCL
+10.03%
$79.93
SMX
+250.80%
$61.04
KWM
+13.63%
$0.75
DNN
0.00%
$2.56
IBRX
+10.79%
$2.36
RIOT
+7.82%
$16.13
AMZN
+1.77%
$233.22
CAN
+9.78%
$1.01
AAPL
+0.46%
$278.85
NWTN
-9.09%
$0.70
AIIO
-9.09%
$0.70
AG
+12.73%
$15.23
WBD
+0.50%
$24.00
VEEE
+45.50%
$2.59
APLD
+8.66%
$27.10
GOOG
-0.05%
$320.12
NGD
+6.50%
$8.35
IREN
-1.32%
$47.81
RIG
+2.55%
$4.41
GRYP
-10.38%
$1.38
BAC
+1.24%
$53.65
MODV
-25.22%
$0.43
AMD
+1.53%
$217.53
RIVN
+4.20%
$16.86
SMR
+5.04%
$20.00
TMC
+19.38%
$6.96
CDE
+6.67%
$17.27
PLTR
+1.61%
$168.45
ITUB
+1.82%
$7.80
CRCA
+19.56%
$4.40
AGNC
+0.47%
$10.49
T
+0.77%
$26.02
AMC
+6.52%
$2.45
VHAI
-25.00%
$0.00
CRCG
+20.00%
$2.82
NVO
+1.31%
$49.35
MSTR
+0.87%
$177.18
NFLX
+1.35%
$107.58
SAND
-6.04%
$12.12
BBD
+0.54%
$3.70
BTE
+1.89%
$3.22
MSFT
+1.34%
$492.01
HBAN
+0.18%
$16.30
HL
+5.32%
$16.82
CRWV
-1.57%
$73.12
LPTX
+368.57%
$2.05
KTTA
+38.67%
$1.47
NVDA
-1.80%
$177.00
HBI
-1.82%
$6.47
AMZE
+21.21%
$0.48
VINE
+21.21%
$0.48
TLRY
-21.06%
$0.81
INTC
+10.18%
$40.56
BITF
+12.25%
$3.48
IPG
-1.95%
$24.57
TWOH
-15.38%
$0.00
BYND
-3.74%
$0.98
YGMZ
-9.59%
$0.11
AXDX
-61.36%
$0.03
BMNR
+4.34%
$33.12
CLSK
+12.26%
$15.10
ADAP
-15.14%
$0.05
RUBI
-26.17%
$0.15
ASST
-0.88%
$1.12
PLUG
+1.51%
$2.01
SOND
-23.45%
$0.12
SNAP
+0.91%
$7.68
RMBL
+60.50%
$3.21
LNW
-3.71%
$86.22
INHD
-0.99%
$0.22
ADD
-25.47%
$0.05
CHR
-3.48%
$0.04
BIYA
+17.05%
$0.29
AAL
+0.86%
$14.05
TSLA
+0.84%
$430.17
SRM
+53.27%
$10.30
CIFR
+6.26%
$20.35
BMNU
+8.84%
$8.18
ONMD
+30.28%
$1.85
ONDS
-4.12%
$7.90
MARA
+6.30%
$11.81
WULF
+4.51%
$15.51
NIO
+0.73%
$5.50
F
+0.68%
$13.28
BURU
+9.84%
$0.24
GPUS
-9.24%
$0.30
WLGS
-5.57%
$0.04
MTSR
-0.35%
$70.50
VALE
+0.79%
$12.61
SOFI
+4.31%
$29.72
GOOGL
+0.07%
$320.18
BTBT
+2.58%
$2.38
DEFT
+9.35%
$1.52
ADTX
+21.01%
$3.80
BTG
+3.35%
$4.62
DVLT
-4.69%
$2.03
GRAB
+2.44%
$5.45
ACHR
+4.00%
$7.79
AFMD
-34.94%
$0.18
PFE
+0.11%
$25.74
CRCL
+10.03%
$79.93
SMX
+250.80%
$61.04
KWM
+13.63%
$0.75
DNN
0.00%
$2.56
IBRX
+10.79%
$2.36
RIOT
+7.82%
$16.13
AMZN
+1.77%
$233.22
CAN
+9.78%
$1.01
AAPL
+0.46%
$278.85
NWTN
-9.09%
$0.70
AIIO
-9.09%
$0.70
AG
+12.73%
$15.23
WBD
+0.50%
$24.00
VEEE
+45.50%
$2.59
APLD
+8.66%
$27.10
GOOG
-0.05%
$320.12
NGD
+6.50%
$8.35
IREN
-1.32%
$47.81
RIG
+2.55%
$4.41
GRYP
-10.38%
$1.38
BAC
+1.24%
$53.65
MODV
-25.22%
$0.43
AMD
+1.53%
$217.53
RIVN
+4.20%
$16.86
SMR
+5.04%
$20.00
TMC
+19.38%
$6.96
CDE
+6.67%
$17.27
PLTR
+1.61%
$168.45
ITUB
+1.82%
$7.80
CRCA
+19.56%
$4.40
AGNC
+0.47%
$10.49
T
+0.77%
$26.02
AMC
+6.52%
$2.45
VHAI
-25.00%
$0.00
CRCG
+20.00%
$2.82
NVO
+1.31%
$49.35
MSTR
+0.87%
$177.18
NFLX
+1.35%
$107.58
SAND
-6.04%
$12.12
BBD
+0.54%
$3.70
BTE
+1.89%
$3.22
MSFT
+1.34%
$492.01
HBAN
+0.18%
$16.30
HL
+5.32%
$16.82
CRWV
-1.57%
$73.12
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.